{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-018333","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.268281+00:00","generated_at":"2026-05-18T08:53:02.950242+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Lipocine hosts KOL event on LPCN 1154 (BRLIZIO™) for postpartum depression","bullets":["Virtual key opinion leader event held July 9, 2025, for LPCN 1154 (BRLIZIO™).","Drug candidate targets postpartum depression; presentation replay on corporate website.","No clinical data or financial guidance disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-018333","json":"https://secwatch.observer/filing/0001641172-25-018333.json","markdown":"https://secwatch.observer/filing/0001641172-25-018333.md","text":"https://secwatch.observer/filing/0001641172-25-018333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225018333/0001641172-25-018333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225018333/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:53:02.950242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}